rs2228440

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002609.4(PDGFRB):​c.3090C>T​(p.Pro1030Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0971 in 1,613,136 control chromosomes in the GnomAD database, including 8,372 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.088 ( 628 hom., cov: 31)
Exomes 𝑓: 0.098 ( 7744 hom. )

Consequence

PDGFRB
NM_002609.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -4.01
Variant links:
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 5-150117665-G-A is Benign according to our data. Variant chr5-150117665-G-A is described in ClinVar as [Benign]. Clinvar id is 258777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-150117665-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDGFRBNM_002609.4 linkc.3090C>T p.Pro1030Pro synonymous_variant Exon 22 of 23 ENST00000261799.9 NP_002600.1 P09619-1Q59F04
PDGFRBNM_001355016.2 linkc.2898C>T p.Pro966Pro synonymous_variant Exon 21 of 22 NP_001341945.1
PDGFRBNM_001355017.2 linkc.2607C>T p.Pro869Pro synonymous_variant Exon 22 of 23 NP_001341946.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDGFRBENST00000261799.9 linkc.3090C>T p.Pro1030Pro synonymous_variant Exon 22 of 23 1 NM_002609.4 ENSP00000261799.4 P09619-1
PDGFRBENST00000520579.5 linkn.*2404C>T non_coding_transcript_exon_variant Exon 22 of 23 1 ENSP00000430026.1 E5RH16
PDGFRBENST00000520579.5 linkn.*2404C>T 3_prime_UTR_variant Exon 22 of 23 1 ENSP00000430026.1 E5RH16

Frequencies

GnomAD3 genomes
AF:
0.0882
AC:
13399
AN:
151928
Hom.:
629
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0851
Gnomad AMI
AF:
0.0987
Gnomad AMR
AF:
0.0864
Gnomad ASJ
AF:
0.116
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0415
Gnomad FIN
AF:
0.0462
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.0858
GnomAD3 exomes
AF:
0.0763
AC:
19165
AN:
251228
Hom.:
896
AF XY:
0.0771
AC XY:
10465
AN XY:
135794
show subpopulations
Gnomad AFR exome
AF:
0.0853
Gnomad AMR exome
AF:
0.0587
Gnomad ASJ exome
AF:
0.110
Gnomad EAS exome
AF:
0.000326
Gnomad SAS exome
AF:
0.0405
Gnomad FIN exome
AF:
0.0550
Gnomad NFE exome
AF:
0.103
Gnomad OTH exome
AF:
0.0821
GnomAD4 exome
AF:
0.0981
AC:
143318
AN:
1461090
Hom.:
7744
Cov.:
32
AF XY:
0.0966
AC XY:
70209
AN XY:
726890
show subpopulations
Gnomad4 AFR exome
AF:
0.0838
Gnomad4 AMR exome
AF:
0.0609
Gnomad4 ASJ exome
AF:
0.110
Gnomad4 EAS exome
AF:
0.000227
Gnomad4 SAS exome
AF:
0.0387
Gnomad4 FIN exome
AF:
0.0600
Gnomad4 NFE exome
AF:
0.110
Gnomad4 OTH exome
AF:
0.0976
GnomAD4 genome
AF:
0.0881
AC:
13398
AN:
152046
Hom.:
628
Cov.:
31
AF XY:
0.0840
AC XY:
6240
AN XY:
74316
show subpopulations
Gnomad4 AFR
AF:
0.0850
Gnomad4 AMR
AF:
0.0863
Gnomad4 ASJ
AF:
0.116
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0417
Gnomad4 FIN
AF:
0.0462
Gnomad4 NFE
AF:
0.106
Gnomad4 OTH
AF:
0.0849
Alfa
AF:
0.0993
Hom.:
724
Bravo
AF:
0.0913
Asia WGS
AF:
0.0250
AC:
87
AN:
3478
EpiCase
AF:
0.107
EpiControl
AF:
0.108

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Acroosteolysis-keloid-like lesions-premature aging syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Basal ganglia calcification, idiopathic, 4 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Myofibromatosis, infantile, 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Jan 10, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Myeloproliferative disorder, chronic, with eosinophilia Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Infantile myofibromatosis;C1866182:Acroosteolysis-keloid-like lesions-premature aging syndrome;C3554321:Basal ganglia calcification, idiopathic, 4;C4225270:Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.78
DANN
Benign
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2228440; hg19: chr5-149497228; API